Home›Companies›Biotech & Pharma›GreenJay Therapeutics

GreenJay Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 22, 2024·Suggest an edit

About GreenJay Therapeutics

GreenJay Therapeutics is a private company based in Houston, Texas, incorporated in 2022 in Delaware. It has reported $1,005,531 raised in two offerings on Form D since June 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetApr 22, 2024$0of $1.0M target0—Equity, Options, Securities on exerciseRule 506(b)Form D ↗
Jan 25, 2023Jun 16, 2023$1,005,531fully sold27$37,242EquityRule 506(b)Form D ↗
Total, two offerings$1,005,531

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GreenJay Therapeutics's Form D filed Apr 22, 2024.

TL
Tommy Lee
Director
BA
MR
JP
James Payne
President

Sources

  1. SECGreenJay Therapeutics, Inc. filing history